Science news articles about 'exemestane aromasin'

... analysis of a breast cancer prevention study using exemestane (Aromasin®) finds an "acceptable" level of bone ... what we've seen in women taking exemestane in the adjuvant treatment setting." Eng-Wong ...

... women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen ... cancer. It is normally taken for five years. Exemestane belongs to a newer class of anti-oestrogen ...

... is studying the effects of an IGF receptor antibody combined with a drug called exemestane (Aromasin® or an aromatase inhibitor that blocks estrogen production) in postmenopausal women. One group of ...

... . Aromatase inhibitors include letrozole (trade name, Femara), anastrazole (Arimidex) and exemestane (Aromasin). Researchers reviewed charts of 238 consecutive postmenopausal patients who had ...